Lithium Bests Newer Drugs for Bipolar Disorder

While it has been around for decades to treat bipolar disorder, the drug lithium works better than newer -– and more expensive –- mood stabilizers in terms of lower rates of self-harm and unintended injury.

Researchers led by Joseph F. Hayes, MSc, MB, ChB, of University College London, looked at rates of self-harm, unintentional injury and suicide deaths in patients prescribed lithium, Depakote (valproate), Zyprexa (olanzapine) or Seroquel (quetiapine). They examined electronic health records of more than 6,671 individuals diagnosed with bipolar disorder and given one of the drugs.

Overall, people who were not taking lithium and were on one of the other mood stabilizers were 40% more likely have harmed themselves in comparison to those on lithium, according to results published in JAMA Psychiatry. Also, those on Depakote were 32% to 34% more likely to sustain an unintended injury.

The finding “supports the hypothesis that lithium use reduces impulsive aggression in addition to stabilizing mood,” the study authors conclude, reinforcing lithium as the “gold standard” in the treatment of bipolar disorder.

However, lithium itself is not without side effects. These include a risk of kidney disease and hypothyroidism, or an underactive thyroid gland. As a result, people on lithium are often required to undergo lab tests every 3 to 6 months to make sure their kidneys are functioning correctly.

Lithium is also far cheaper than the other drugs examined in the study. For example, a 2008 studyfound that Zyprexa is $500 more expensive per month than lithium.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement